Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolide Effect on IL-18 in Bronchiectasis
NCT02491723Completed
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in bronchiectasis. Primary endpoint: Interleukin-18. Started Jan 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02491723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491723.